China Resources Double-Crane Pharmaceutical's subsidiary, Acetic Acid Sodium Ringer Injection, has obtained a drug registration certificate.
China Resources Shuanghe (600062.SH) announced that its wholly-owned subsidiary, Xi'an Jingxi Shuanghe Pharmaceutical Co., Ltd. (referred to as "Jingxi Shuanghe"), recently received the "Drug Registration Certificate" for sodium acetate Ringer's Injection issued by the National Medical Products Administration. Sodium acetate Ringer's Injection is used to replenish extracellular fluid when circulating blood volume and interstitial fluid decrease, as well as to correct metabolic acidosis.
China Resources Double-Crane Pharmaceutical (600062.SH) announced that its wholly-owned subsidiary, Xi'an Jingxi Double-Crane Pharmaceutical Co., Ltd. (referred to as "Jingxi Double-Crane"), recently received the "Drug Registration Certificate" for Sodium Acetate Ringer's Injection from the National Medical Products Administration. Sodium Acetate Ringer's Injection is used to supplement extracellular fluid when circulating blood volume and interstitial fluid are reduced, and to correct metabolic acidosis.
Related Articles
.png)
US Stock Market Move | Q4 performance and revenue outlook exceed expectations, Marvell Technology, Inc. (MRVL.US) is up over 16.8%.
US Stock Market Move | BlackRock, Inc. (BLK.US) falls more than 5%, $25 million private lending valuation drops to zero
As Paramount Sky (PSKY.US) acquisition transaction progresses, Warner Bros. Discovery (WBD.US) CEO and other executives collectively sold over 200 million dollars worth of company stocks.
US Stock Market Move | Q4 performance and revenue outlook exceed expectations, Marvell Technology, Inc. (MRVL.US) is up over 16.8%.
US Stock Market Move | BlackRock, Inc. (BLK.US) falls more than 5%, $25 million private lending valuation drops to zero
As Paramount Sky (PSKY.US) acquisition transaction progresses, Warner Bros. Discovery (WBD.US) CEO and other executives collectively sold over 200 million dollars worth of company stocks.
RECOMMEND
